{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:08:53Z","timestamp":1774408133914,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270551"],"award-info":[{"award-number":["82270551"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108005"],"award-info":[{"award-number":["81820108005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900502"],"award-info":[{"award-number":["81900502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2021ZDLSF02-07"],"award-info":[{"award-number":["2021ZDLSF02-07"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2023KJXX-026"],"award-info":[{"award-number":["2023KJXX-026"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12072-025-10820-8","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T07:04:01Z","timestamp":1743404641000},"page":"929-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk stratification for patients with primary biliary cholangitis: early versus advanced-stage or non-cirrhosis versus cirrhosis?"],"prefix":"10.1007","volume":"19","author":[{"given":"Dawei","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanya","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-9507","authenticated-orcid":false,"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"10266","key":"10820_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","volume":"396","author":"A Lleo","year":"2020","unstructured":"Lleo A, Wang GQ, Gershwin ME, Hirschfield GM. Primary biliary cholangitis. Lancet. 2020;396(10266):1915\u20131926","journal-title":"Lancet"},{"issue":"1","key":"10820_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","volume":"16","author":"H You","year":"2022","unstructured":"You H, Ma X, Efe C, et al. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int. 2022;16(1):1\u201323","journal-title":"Hepatol Int"},{"issue":"1","key":"10820_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"GM Hirschfield","year":"2017","unstructured":"Hirschfield GM, Beuers U, Corpechot C, Invernizzi P, Jones D, Marzioni M. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u2013172","journal-title":"J Hepatol"},{"issue":"2","key":"10820_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71(2):357\u2013365","journal-title":"J Hepatol"},{"issue":"3","key":"10820_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2019.08.013","volume":"18","author":"NK Gatselis","year":"2020","unstructured":"Gatselis NK, Goet JC, Zachou K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis. Clin Gastroenterol Hepatol. 2020;18(3):684-692.e6","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10820_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1184252","author":"Y Yang","year":"2023","unstructured":"Yang Y, He X, Rojas M, Leung PSC, Gao L. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1184252","journal-title":"Front Immunol"},{"issue":"3","key":"10820_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48(3):871\u2013877","journal-title":"Hepatology"},{"issue":"1","key":"10820_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","volume":"67","author":"EASL Clinical Practice Guidelines","year":"2017","unstructured":"EASL Clinical Practice Guidelines. The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67(1):145\u2013172","journal-title":"J Hepatol"},{"issue":"6","key":"10820_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55(6):1361\u20131367","journal-title":"J Hepatol"},{"issue":"4","key":"10820_CR10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EMM Kuiper","year":"2009","unstructured":"Kuiper EMM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136(4):1281\u20131287","journal-title":"Gastroenterology"},{"issue":"10","key":"10820_CR11","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105(10):2186\u20132194","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10820_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12072-023-10587-w","volume":"18","author":"D Ding","year":"2024","unstructured":"Ding D, Guo G, Cui L, et al. Prognostic significance of liver stiffness in patients with primary biliary cholangitis: validation of Baveno VII criteria. Hep Intl. 2024;18(1):206\u2013215","journal-title":"Hep Intl"},{"issue":"6","key":"10820_CR13","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","volume":"77","author":"C Corpechot","year":"2022","unstructured":"Corpechot C, Carrat F, Gaouar F, et al. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis. J Hepatol. 2022;77(6):1545\u20131553","journal-title":"J Hepatol"},{"issue":"12","key":"10820_CR14","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1002\/hep4.2103","volume":"6","author":"D Ding","year":"2022","unstructured":"Ding D, Guo G, Liu Y, et al. Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid. Hepatol Commun. 2022;6(12):3487\u20133495","journal-title":"Hepatol Commun"},{"issue":"4","key":"10820_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, et al. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China. Gastroenterology. 2023;165(4):1025\u20131040","journal-title":"Gastroenterology"},{"key":"10820_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-024-10743-w","author":"D Ding","year":"2024","unstructured":"Ding D, Hu Y, Jia G, et al. Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment. Hepatol Int. 2024. https:\/\/doi.org\/10.1007\/s12072-024-10743-w","journal-title":"Hepatol Int"},{"issue":"6","key":"10820_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/hep4.1907","volume":"6","author":"D Ding","year":"2022","unstructured":"Ding D, Xuan G, Hu Y, et al. Immunoglobulin M: a neglected serum biomarker in treatment-naive primary biliary cholangitis with normal alkaline phosphatase. Hepatol Commun. 2022;6(6):1403\u20131412","journal-title":"Hepatol Commun"},{"issue":"1","key":"10820_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.25599","volume":"56","author":"C Corpechot","year":"2012","unstructured":"Corpechot C, Carrat F, Poujol-Robert A, et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology. 2012;56(1):198\u2013208","journal-title":"Hepatology"},{"issue":"10","key":"10820_CR19","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/apt.15533","volume":"50","author":"CF Murillo Perez","year":"2019","unstructured":"Murillo Perez CF, Hirschfield GM, Corpechot C, et al. Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Aliment Pharmacol Ther. 2019;50(10):1127\u20131136","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10820_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/HEP.0000000000000529","volume":"79","author":"C Corpechot","year":"2024","unstructured":"Corpechot C, Lemoinne S, Soret P, et al. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: to what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? Hepatology. 2024;79(1):39\u201348","journal-title":"Hepatology"},{"issue":"10","key":"10820_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101168","volume":"6","author":"SB Roberts","year":"2024","unstructured":"Roberts SB, Choi WJ, Worobetz L, et al. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis. JHEP Rep. 2024;6(10): 101168","journal-title":"JHEP Rep"},{"issue":"7","key":"10820_CR22","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","volume":"149","author":"WJ Lammers","year":"2015","unstructured":"Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149(7):1804-1812.e4","journal-title":"Gastroenterology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10820-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:30:10Z","timestamp":1757147410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10820-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10820"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10820-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}